A I Idris Selected Research

Flurbiprofen (Froben)

9/2004

The flurbiprofen derivatives HCT1026 and HCT1027 inhibit bone resorption by a mechanism independent of COX inhibition and nitric oxide production.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

A I Idris Research Topics

Disease

2	Bone Diseases (Bone Disease) 03/2012 - 09/2004
1	Neoplasms (Cancer) 03/2012
1	Osteolysis 03/2012
1	Breast Neoplasms (Breast Cancer) 03/2012
1	Inflammation (Inflammations) 03/2012
1	Bone Resorption 09/2004

Drug/Important Bio-Agent (IBA)

2	ProstaglandinsIBA 03/2012 - 09/2004
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 03/2012
1	2- ((2,6- dichlorophenyl)amino)benzeneacetic acid 4-(3H-1,2-dithiol-3-thione-5-yl)phenyl esterIBA 03/2012
1	Diclofenac (SR 38)FDA LinkGeneric 03/2012
1	2-((2,6-dichlorophenyl)amino) benzeneacetic acid 4-(3-thioxo-3H-1,2-dithiol-5-yl) phenyl esterIBA 03/2012
1	HydrogenIBA 03/2012
1	(3- (2,6- dichloro- phenylamino)phenyl)acetic acid 2-methanesulphonylsulphanyl ethyl esterIBA 03/2012
1	Bone Density Conservation AgentsIBA 09/2004
1	HCT1027IBA 09/2004
1	Flurbiprofen (Froben)FDA LinkGeneric 09/2004
1	InterleukinsIBA 09/2004
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 09/2004
1	nitroflurbiprofenIBA 09/2004